Published by Josh White on 31st October 2024
(Sharecast News) - Hutchmed China announced on Thursday that it was set to receive a $20m milestone payment from its partner Takeda, after sales of 'Fruzaqla', or fruquintinib, surpassed $200m.
URL: http://www.digitallook.com/dl/news/story/34660967/...